Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Chromocell Therapeutics Corp ( (CHRO) ) just unveiled an update.
Channel Therapeutics Corporation, formerly Chromocell Therapeutics, has rebranded and reincorporated to emphasize its focus on non-opioid pain treatments using sodium channel modulation. The company is advancing its therapeutic programs, including eye pain and depot programs, with efficacy results anticipated soon. This strategic move is aimed at enhancing growth, valuation, and tax benefits.
Find detailed analytics on CHRO stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue